ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases.
Saved in:
| Title: | ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases. |
|---|---|
| Authors: | Lobanova E; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. el519@cam.ac.uk.; UK Dementia Research Institute at University of Cambridge, Cambridge, CB2 0XY, UK. el519@cam.ac.uk., Zhang YP; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.; UK Dementia Research Institute at University of Cambridge, Cambridge, CB2 0XY, UK., Emin D; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.; UK Dementia Research Institute at University of Cambridge, Cambridge, CB2 0XY, UK., Brelstaff J; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK., Kahanawita L; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK., Malpetti M; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK., Quaegebeur A; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK., Triantafilou K; School of Medicine, Division of Infection and Immunity, University Hospital of Wales, Cardiff University, Cardiff, UK., Triantafilou M; School of Medicine, Division of Infection and Immunity, University Hospital of Wales, Cardiff University, Cardiff, UK., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Rowe JB; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK., Williams-Gray CH; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK., Bryant CE; Department of Medicine, Box 157, Level 5, Addenbrookes Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK., Klenerman D; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. dk10012@cam.ac.uk.; UK Dementia Research Institute at University of Cambridge, Cambridge, CB2 0XY, UK. dk10012@cam.ac.uk. |
| Source: | Nature communications [Nat Commun] 2024 Nov 11; Vol. 15 (1), pp. 9690. Date of Electronic Publication: 2024 Nov 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-53547-0 |
